Vaccines List

TAK-214 Norovirus Vaccine

TAK-214 a vaccine candidate uses virus-like particle (VLP) antigens, which are proteins that precisely mimic the outer surface of norovirus. The vaccine includes antigens from genotypes GI.1 and GII.4, to represent both of the genogroups that cause the majority of human illness.Read more...

TAK-426 Zika Vaccine

TAK-426 (PIZV) is a purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate.Read more...

Tembexa Oral Antiviral

Tembexa (brincidofovir) oral antiviral is approved for the treatment of smallpoxRead more...

TetraVax-DV (V180) Dengue Vaccine

Instituto Butantan TetraVax-DV, V180, and TV003 is inactivated dengue vaccine candidate.Read more...

TG4001 HPV Cancer Vaccine

TG4001 is a therapeutic cancer vaccine candidate.Read more...

TG4050 Cancer Vaccine

Transgene TG4050 is an individualized therapeutic vaccine designed to stimulate and educate the immune system of patients to recognize and destroy tumor cells. Read more...

TicoVac Tick-Borne Encephalitis (TBE) Vaccine

Pfizer TicoVac tick-borne encephalitis vaccine is indicated to prevent TBE in individuals one year of age and older.Read more...

TIV High Dose Influenza Vaccine

UK marketing authorization was granted for Sanofi Pasteur’s Trivalent Influenza Vaccine High Dose. TIV High Dose is approved for the prevention of influenza in people 65 years of age and older,1 a population that is particularly vulnerable to influenza infection and its complications2Read more...

TNX-801 Monkeypox Vaccine

TNX-801 is a vaccine candidate to protect against monkeypox and smallpox.Read more...

TPOXX Smallpox Mpox Treatment

TPOXX Tecovirimat Smallpox Mpox treatment available in both oral and IV formulations.Read more...

Trumenba Meningitis B Vaccine

Trumenba (MenB-FHbp) is a sterile suspension composed of two recombinant lipidated factor H binding protein (fHBP) variants from N.Read more...

Twinrix Hepatitis Vaccine

Twinrix is a bivalent vaccine that is indicated for active immunization against disease caused by hepatitis A virus and infection by all known subtypes of hepatitis B virus. Read more...

TY014 Anti-Yellow Fever Monoclonal Antibody

TY014 will be the first therapeutic monoclonal antibody specifically targeting the Yellow Fever Virus to enter clinical trials.Read more...

Typbar TCV Typhoid Vaccine

Typbar TCV is the world’s first clinically proven conjugate Typhoid vaccine.Read more...

Typhim VI Typhoid Vaccine

Typhim VI protects against the risk of infection related to Salmonella typh i but it does not confer vis-à-vis protection of Salmonella Paratyphi A or B, or non-typhoid salmonella.Read more...